China Pharma Holdings, Inc. (CPHI) Reports Q1 Loss of $0.01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St declines as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Oppenheimer sees AI software winners as focus shifts to ROI
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Accenture (ACN) call put ratio 1 call to 1.2 puts into quarter results
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
China Pharma Holdings, Inc. Reports First Quarter 2018 Financial Results
May 15, 2018 6:00 AM EDTHAIKOU, China, May 15, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended March 31, 2018.
First Quarter Highlights
Revenue increased 10.1% to $3.6 million in first quarter 2018 from $3.3 million in the same period of 2017; Gross margin was 29.1% in first quarter 2018, compared to 21.9% in the same period of 2017; Loss from operations was $0.1 million in first quarter 2018 compared to $0.8 million... More